Tempus AI Inc (TEM) Stock Price & News

Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." Wikipedia

About Tempus AI Inc

CEOEric Lefkofsky

Employees3.8K

Founded2015

HeadquartersChicago, Illinois, United States

SectorHealth care

Websitetempus.com

Analyst	Recommendation	Action	Price target	Projected	Date
Subbu Nambi Guggenheim	Buy	Maintained	$92.00	+30.8%	10/01/2026
Evie Koslosky Goldman Sachs	Hold	Initiated	$75.00	+6.6%	09/22/2026
Yi Chen H.C. Wainwright	Buy	Reiterated	$66.00	-6.2%	09/11/2026
Unknown Analyst UBS	Hold	Initiated	$70.00	-0.5%	09/08/2026
Doug Schenkel UBS	Hold	Initiated	$70.00	-0.5%	09/09/2026
Jamie Clark Rothschild & Co Redburn	Hold	Initiated	$67.00	-4.8%	09/08/2026
Sarah James Cantor Fitzgerald	Buy	Initiated	$80.00	+13.7%	09/02/2026
Kyle Mikson CFA Canaccord Genuity	Buy	Maintained	$80.00	+13.7%	09/01/2026
David Westenberg Piper Sandler	Buy	Upgraded	$76.00	+8%	09/01/2026
Eugene Mannheimer Freedom Capital Markets	Hold	Maintained	$73.00	+3.8%	08/31/2026
Mark Massaro BTIG	Buy	Maintained	$80.00	+13.7%	08/20/2026
Casey Woodring J.P. Morgan	Hold	Maintained	$45.00	-36%	08/04/2026
Michael Ryskin Bank of America Securities	Hold	Reiterated	$52.00	-26.1%	08/03/2026
Daniel Arias Stifel Nicolaus	Hold	Maintained	$50.00	-28.9%	08/03/2026
Catherine Ramsey Schulte Robert W. Baird	Buy	Maintained	$59.00	-16.1%	07/31/2026
Matt Larew William Blair	Hold	Reiterated	-	-	07/31/2026
Ryan MacDonald Needham	Buy	Reiterated	$75.00	+6.6%	07/31/2026
Daniel Brennan TD Cowen	Buy	Maintained	$71.00	+0.9%	07/15/2026
Kallum Titchmarsh Morgan Stanley	Buy	Maintained	$70.00	-0.5%	07/10/2026
Paige Chamberlain‏ Wolfe Research	Hold	Initiated	-	-	06/01/2026
Unknown Analyst Wolfe Research	Hold	Initiated	-	-	06/01/2026
Andrew Brackmann William Blair	Hold	Reiterated	-	-	06/01/2026
Anthony Petrone Mizuho Securities	Buy	Maintained	$100.00	+42.1%	04/13/2026
Tycho Peterson Jefferies	Sell	Initiated	$35.00	-50.2%	04/12/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	334.21M	367.21M	348.12M	382.49M
Cost of goods sold	124.26M	129.50M	126.08M	135.99M
Cost of revenue	124.26M	129.50M	126.08M	135.99M
Research and development expenses	83.05M	90.62M	94.16M	96.57M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	187.39M	208.41M	212.60M	226.84M
Operating expense	270.44M	299.03M	306.76M	323.40M
Total operating expenses	394.70M	428.52M	432.83M	459.39M
Operating income	-60.50M	-61.31M	-84.72M	-76.90M
Other non operating income	3.88M	2.83M	4.60M	4.28M
EBT including unusual items	-79.71M	-60.16M	-125.98M	5.95M
EBT excluding unusual items	-65.90M	-71.80M	-93.68M	-81.87M
Income tax expense	276.00K	-5.99M	-62.00K	309.00K
Effective tax rate	-0.35%	9.96%	0.05%	5.19%
Other operating expenses	-	-	-	-
Net income	-79.98M	-54.17M	-125.92M	5.64M
Net profit margin	-23.93%	-14.75%	-36.17%	1.48%
Earnings per share	-0.11	-0.04	-0.13	-0.04
Interest and investment income	4.60M	5.12M	3.87M	3.90M
Interest expense	-15.40M	-15.29M	-14.34M	-10.28M
Net interest expenses	-10.80M	-10.16M	-10.48M	-6.39M
Depreciation and amortization charges	-	-	-	-
EBITDA	-40.69M	-41.71M	-58.54M	-50.92M
Gain or loss from assets sale	-	415.00K	334.00K	41.00K

Ask anything